| Literature DB >> 27752600 |
Tae Gwan Oh1, Won Chul Cha1, Ik Joon Jo1, Mun Ju Kang2, Dong Woo Lee2.
Abstract
OBJECTIVE: We aimed to summarize the therapeutic hypothermia (TH) protocols used in emergency departments (EDs) in Korea and to investigate the differences between level 1 and 2 centers.Entities:
Keywords: Clinical protocols; Heart arrest; Hypothermia; Republic of Korea
Year: 2015 PMID: 27752600 PMCID: PMC5052908 DOI: 10.15441/ceem.15.018
Source DB: PubMed Journal: Clin Exp Emerg Med ISSN: 2383-4625
Questions about general information regarding therapeutic hypothermia
| Questions | Level 1 (n = 10) | Level 2 (n = 26) | Overall (n = 36) | P-value |
|---|---|---|---|---|
| Is TH standard of care in your institute? | 14 (100.0) | 24 (92.3) | 34 (94.4) | 0.37 |
| How many times do you perform TH in a month? (average [SD]) | 5.95 (3.44) | 3.28 (2.93) | 4.02 (3.27) | 0.01 |
| Do you have a written protocol for TH? | 8 (80.0) | 19 (73.1) | 27 (75.0) | 0.67 |
| Indications for your TH include the following? | ||||
| Out-of-hospital cardiac arrest | 9 (90.0) | 23 (88.5) | 32 (88.9) | 0.90 |
| In-hospital cardiac arrest | 9 (90.0) | 22 (84.6) | 31 (86.1) | 0.68 |
| Unwitnessed cardiac arrest | 9 (90.0) | 21 (80.8) | 30 (83.3) | 0.51 |
| Pediatric cardiac arrest | 5 (80.0) | 8 (30.8) | 13 (36.1) | 0.28 |
| Contraindications for your TH include the following? | ||||
| Active bleeding | 7 (70.0) | 17 (65.4) | 24 (66.7) | 0.79 |
| Terminal illness | 6 (60.0) | 19 (73.1) | 25 (69.4) | 0.45 |
| Trauma | 1 (10.0) | 11 (42.3) | 12 (33.3) | 0.07 |
| Poor pre-arrest state | 1 (10.0) | 9 (34.6) | 10 (27.8) | 0.14 |
| Severe sepsis | 4 (40.0) | 7 (26.9) | 11 (30.6) | 0.45 |
| Pregnancy | 3 (30.0) | 5 (19.2) | 8 (22.2) | 0.49 |
| Uncontrolled arrhythmia | 1 (10.0) | 2 (7.69) | 3 (8.33) | 0.82 |
| Refractory shock | 3 (30.0) | 6 (23.1) | 9 (25.0) | 0.67 |
| Do-not-resuscitate state | 7 (70.0) | 23 (88.5) | 30 (83.3) | 0.18 |
Values are presented as number (%) unless otherwise indicated.
TH, therapeutic hypothermia; SD, standard deviation.
Fig. 1.The locations of the emergency departments that were enrolled or excluded from this study are depicted. The existence (or absence) of a written therapeutic hypothermia (TH) protocol is also demonstrated.
Questions about induction of therapeutic hypothermia
| Questions | Level 1 (n = 10) | Level 2 (n = 26) | Overall (n = 36) | P-value |
|---|---|---|---|---|
| How do you measure body temperature? | ||||
| Esophageal probe | 6 (60.0) | 8 (30.8) | 14 (38.9) | 0.11 |
| Rectal probe | 4 (40.0) | 14 (53.9) | 18 (50.0) | 0.46 |
| Tympanic membrane | 1 (10.0) | 0 (0) | 0 (0) | 0.10 |
| Axilla | 0 (0) | 0 (0) | 0 (0) | NA |
| Bladder | 1 (10.0) | 2 (7.7) | 3 (8.3) | 0.82 |
| What sedatives and analgesics do you use for TH? | ||||
| Midazolam | 8 (80.0) | 21 (80.8) | 29 (80.6) | 0.96 |
| Lorazepam | 1 (10.0) | 2 (7.7) | 3 (8.3) | 0.82 |
| Propofol | 1 (10.0) | 0 (0) | 1 (2.8) | 0.10 |
| Dexmedetomidine | 2 (20.0) | 1 (3.9) | 3 (8.3) | 0.12 |
| Pethidine | 1 (10.0) | 1 (3.9) | 2 (5.6) | 0.47 |
| Fentanyl | 3 (30.0) | 5 (19.2) | 8 (22.2) | 0.49 |
| Remifentanyl | 8 (80.0) | 9 (34.6) | 17 (47.2) | 0.02 |
| Do you routinely use neuromuscular blockers? | 8 (80.0) | 16 (61.5) | 24 (66.7) | 0.29 |
| Do you routinely use preventive anticonvulsants? | 3 (30.0) | 2 (7.7) | 5 (13.9) | 0.08 |
| Do you alter target temperature of TH for each case? | 8 (80.0) | 17 (65.4) | 25 (67.4) | 0.39 |
| What is your routine target temperature? (average [SD]) | 33.4 (0.63) | 33.5 (0.97) | 33.4 (0.80) | 0.72 |
| What inducing methods do you use for TH? | ||||
| Infusion of cold saline | 8 (80.0) | 14 (53.9) | 22 (66.1) | 0.15 |
| L-tube irrigation | 1 (10.0) | 2 (7.7) | 3 (8.3) | 0.82 |
| Bladder irrigation | 4 (40.0) | 2 (7.7) | 6 (16.7) | 0.02 |
| Evaporation | 0 (0) | 1 (3.9) | 1 (2.8) | 0.53 |
| Fans | 1 (10.0) | 1 (3.9) | 2 (5.6) | 0.47 |
| External cooling with mechanical device | 10 (100.0) | 18 (49.2) | 28 (77.8) | 0.05 |
| Internal cooling with mechanical device | 2 (20.0) | 7 (26.9) | 9 (25.0) | 0.67 |
Values are presented as number (%) unless otherwise indicated.
TH, therapeutic hypothermia; NA, not applicable; SD, standard deviation.
Questions about maintaining and rewarming after therapeutic hypothermia
| Questions | Level 1 (n = 10) | Level 2 (n = 26) | Overall (n = 36) | P-value |
|---|---|---|---|---|
| What is your target mean arterial pressure during TH? (mmHg) | ||||
| ≥ 55 | 0 (0) | 0 (0) | 0 (0) | 0.29 |
| ≥ 65 | 8 (80.0) | 24 (92.3) | 32 (88.9) | - |
| ≥ 75 | 2 (20.0) | 2 (7.7) | 4 (11.1) | - |
| What is your target PaCO2 during TH? (mmHg) | ||||
| < 40 | 0 (0) | 3 (11.5) | 3 (8.3) | 0.13 |
| 40 ≤ ≤ 45 | 10 (100.0) | 21 (80.8) | 31 (86.1) | - |
| < 45 | 0 (0) | 2 (7.7) | 2 (5.6) | - |
| What is your target TH duration? (hr) | ||||
| 12 | 0 (0) | 0 (0) | 0 (0) | NA |
| 24 | 14 (100) | 13 (100) | 27 (100) | - |
| 36 | 0 (0) | 0 (0) | 0 (0) | - |
| What is your definition of normothermia? (°C) | ||||
| 35.0 | 0 (0) | 1 (3.9) | 1 (2.8) | - |
| 36.0 | 5 (50.0) | 17 (65.4) | 22 (61.1) | - |
| 36.5 | 5 (50.0) | 6 (23.1) | 11 (30.6) | - |
| 36.8 | 0 (0) | 1 (3.9) | 1 (2.8) | - |
| 37.0 | 0 (0) | 1 (3.9) | 1 (2.8) | - |
| What is your rewarming rate? (°C/hr) | ||||
| < 0.2 | 3 (21.4) | 4 (30.8) | 7 (25.9) | 0.76 |
| 0.2 ≤ < 0.4 | 9 (64.3) | 8 (61.5) | 17 (63.0) | - |
| ≥ 0.4 | 1 (7.14) | 0 (0) | 1 (3.70) | - |
| No control on rewarming rate | 1 (7.14) | 1 (7.69) | 2 (7.41) | - |
Values are presented as number (%) unless otherwise indicated.
TH, therapeutic hypothermia; NA, not applicable.
Methods used for neurological prognostication
| Questions | Level 1 (n = 10) | Level 2 (n = 26) | Overall (n = 36) | P-value |
|---|---|---|---|---|
| Imaging tests | ||||
| Brain magnetic resonance imaging | 6 (60.0) | 15 (57.7) | 21 (58.3) | 0.90 |
| Brain computed tomography | 6 (60.0) | 15 (57.7) | 21 (58.3) | 0.90 |
| Neurophysiolgic tests | ||||
| Somato-sensory evoked potential | 2 (20.0) | 3 (11.5) | 5 (13.9) | 0.51 |
| Visual evoked potential | 0 (0) | 2 (7.7) | 2 (5.6) | 0.37 |
| Bispectral index | 2 (20.0) | 1 (3.9) | 3 (8.3) | 0.12 |
| EEG | 7 (70.0) | 16 (61.5) | 23 (63.9) | 0.64 |
| aEEG | 0 (0) | 2 (7.7) | 2 (5.6) | 0.37 |
| Biomarkers | ||||
| Neuron-specific enolase | 5 (50.0) | 8 (30.8) | 13 (36.1) | 0.28 |
| S-100 | 5 (50.0) | 2 (7.69) | 7 (19.4) | 0.01 |
| Procalcitonin | 3 (30.0) | 3 (11.5) | 6 (16.7) | 0.18 |
| Do you routinely use portable EEG? | 7 (70.0) | 11 (42.3) | 18 (50.0) | 0.14 |
Values are presented as number (%) unless otherwise indicated.
EEG, electroencephalography; aEEG, amplitude-integrated EEG.